Advertisement


Related Videos

Issues in Oncology

The ASCO Post Staff

Deborah Schrag, MD, MPH, on Clinical Trial Design: Statistical Options and Challenges

Deborah Schrag, MD, MPH, of Dana-Farber Cancer Institute, offers her perspective on near-equivalence, Bayesian noninferiority, and the value of cancer drug optimization.

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Amit Sanyal, MD: A Clinician’s Perspective

David A. Hyman, MD, JD, on Inclusive Shared Savings

Advertisement

Advertisement



Feb
06
Today In Oncology
Preclinical Study Shows Losartan May Prevent Immune Checkpoint Inhibitor Induced Cerebral Edema in Glioblastoma
Researchers Uncover Racial and Ethnic Disparities in Widely Used Precision Oncology Data Registry
Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer and High FRa Expression
ctDNA as a Prognostic Marker in Intermediate-Risk Rhabdomyosarcoma
Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer in Survivors of Hodgkin Lymphoma
View More 
Advertisement
© 2023 HSP News Service, L.L.C.
Designed by Harborside